This MedLibrary.org supplementary page on IMS Health is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
 |
This article needs additional citations for verification. Please help improve this article by adding reliable references. Unsourced material may be challenged and removed. (July 2007) |
| IMS Health | |
|---|---|
 |
|
| Type | Public |
| Founded | 1954 |
| Headquarters | Norwalk, Connecticut |
| Key people | David Carlucci, CEO and Chairman |
| Industry | Marketing Research |
| Products | Market Research |
| Employees | 7,600+ |
| Website | www.imshealth.com |
IMS Health (NYSE: RX) is an intern consulting and data services company that supplies the pharmaceutical industry with sales data and consulting services. IMS Health was founded in 1954 by Bill Froch and David Dow. Today IMS has operations in more than 100 countries, a global workforce of 7,600+ employees and revenues of $2bn. It recently moved its headquarters from Fairfield, CT to Norwalk, CT.
Contents |
Products
IMS collects pharmaceutical sales data from markets across the world. As of January 2007, they collect sales data from 75% of prescriptions in 100 countries around the world. In the U.S. they are able to cover 90% of pharmaceutical sales. This allows IMS to cover over one million pharmaceutical products from over 3,000 companies.[1]
IMS also uses their own data to produce syndicated reports such as market forecasts. These predict how a market in a specific country or specific therapy area will change over time. This works through the production of baseline projections of sales and the application of different future events to this baseline to produce a forecast.
In January 2008, IMS announced a 11% layoff of their global workforce.
History
- IMS Health's corporate headquarters are located in Norwalk, Connecticut.
- The company's chief executive is David Carlucci, formerly of IBM.
- In 2001, IMS strengthened its consulting capabilities by acquiring Cambridge Pharma Consultancy, a privately held international firm that provides strategic advice to senior pharmaceutical management.
- In 2007 IMS was named 25 in The Business Week 50. This list represents companies that represent the "best in class" companies from the ten economic sectors that make up the S&P 500.[2]
Financial Performance
Top 10 of the Market Research Sector 2006
| Rank | Company | Sales in 2006 (million USD) |
Growth in % |
|---|---|---|---|
| 1 | Nielsen Company | 3,696.0 | 2.6 |
| 2 | IMS Health Inc. | 1,958.6 | 8.9 |
| 3 | Taylor Nelson Sofres | 1,851.1 | 2.5 |
| 4 | Kantar Group | 1,401.4 | 4.1 |
| 5 | GfK AG | 1,397.3 | 5.4 |
| 6 | Ipsos | 1,077.0 | 6.5 |
| 7 | Synovate | 739.6 | 9.5 |
| 8 | IRI | 665.0 | 6.6 |
| 9 | Westat | 425.8 | 0.8 |
| 10 | Arbitron | 329.3 | 5.9 |
References and external links
 |
This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |
This United States corporation or company article is a stub. You can help Wikipedia by expanding it.
Wikipedia content modification information:
- This page was last modified on 20 June 2008, at 11:45.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "IMS Health".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.